Long-Term Liabilities: The sum of all non-current liabilities.
Relay Therapeutics, Inc. (RLAY) had Long-Term Liabilities of $23.54M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-81.75M |
|
-- |
|
-- |
|
$90.25M |
|
$-90.25M |
|
$8.50M |
|
$-81.75M |
|
$-81.75M |
|
$-81.75M |
|
$-81.75M |
|
$-81.75M |
|
$-81.75M |
|
$-90.25M |
|
$-90.86M |
|
219.16M |
|
219.16M |
|
$-0.37 |
|
$-0.37 |
|
| Balance Sheet Financials | |
$864.85M |
|
$0.58M |
|
$36.84M |
|
$901.69M |
|
$59.15M |
|
-- |
|
|
Long-Term Liabilities |
$23.54M |
$82.70M |
|
$819.00M |
|
$814.25M |
|
$819.00M |
|
219.50M |
|
| Cash Flow Statement Financials | |
$-169.16M |
|
$-257.75M |
|
$466.94M |
|
$85.35M |
|
$125.38M |
|
$40.03M |
|
$29.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-169.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.98% |
|
-10.04% |
|
-9.07% |
|
-9.98% |
|
$3.73 |
|
$-0.77 |
|
$-0.77 |
|